Compare VNDA & NODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VNDA | NODK |
|---|---|---|
| Founded | 2002 | 1946 |
| Country | United States | United States |
| Employees | N/A | 172 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.0M | 301.2M |
| IPO Year | 2005 | 2016 |
| Metric | VNDA | NODK |
|---|---|---|
| Price | $3.44 | $14.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 11.6K |
| Earning Date | 10-28-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.87 |
| Revenue | $216,105,000.00 | ★ $285,050,000.00 |
| Revenue This Year | $12.05 | N/A |
| Revenue Next Year | $30.61 | N/A |
| P/E Ratio | ★ N/A | $17.01 |
| Revenue Growth | ★ 8.72 | N/A |
| 52 Week Low | $3.57 | $12.37 |
| 52 Week High | $9.91 | $16.70 |
| Indicator | VNDA | NODK |
|---|---|---|
| Relative Strength Index (RSI) | 32.18 | 49.95 |
| Support Level | N/A | $14.80 |
| Resistance Level | $5.49 | $15.78 |
| Average True Range (ATR) | 0.23 | 0.49 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 0.00 | 33.48 |
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
NI Holdings Inc is a stockholding company. Through its subsidiaries, the company operates in the insurance industry, offering homeowners and farmowners insurance policies, crop insurance policies, home insurance policies, etc. These insurance products are distributed through a network of exclusive and independent agents across the United States. The group's reportable segments are: Private Passenger Auto, Non-Standard Auto, Home and Farm, Crop, and All Other (which mainly consists of commercial, assumed reinsurance, and its excess liability business). Maximum revenue is generated from the Home and Farm segment.